other material
confidence high
sentiment neutral
materiality 0.50
PAVmed stockholders approve stock issuance, charter amendment, and equity plan increase at special meeting
PAVmed Inc.
- Approved issuance of shares upon conversion of 60,000 Series D Preferred shares and shares under Convertible Note (640,946 for, 72,380 against).
- Approved charter amendment enabling director removal with or without cause by majority vote (858,651 for, 60,825 against); filed and effective March 27, 2026.
- Approved amendment to 2014 Long-Term Incentive Equity Plan, increasing authorized shares by 1,500,000 to 1,713,517 (756,683 for, 162,305 against).
- Stockholders representing 54.1% of voting power were present at the special meeting.